Allena Pharmaceuticals Inc. (ALNA) NASDAQ
$0.08 - (-)
Market Cap: -
As of 09/07/22 12:00 AM EDT. Market closed.
Allena Pharmaceuticals Inc. (ALNA)
NASDAQ
$0.08
- (-)
Market Cap: -
As of 09/07/22 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Louis Brenner
Full Time Employees
41
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Louis Brenner
Full Time Employees
41
CEO Compensation (Base)
$539,174
Address
1 Newton Executive Park Ste 202, Massachusetts, Newton, 02462-1435.
PRICE CHART FOR ALLENA PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.06
Previous Close
$0.08
Days Range
$0.06 - $0.15
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
122,083,226
Open
$0.06
Previous Close
$0.08
Days Range
$0.06 - $0.15
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
122,083,226
FINANCIAL STATEMENTS FOR ALLENA PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR ALLENA PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
BRENNER LOUIS MD | President and CEO | Nov 15, 2021 | Sale | $0.81 | 40,328 | 32,666 | 288,576 | Nov 17, 2021, 05:00 PM |
WHOLIHAN EDWARD | Chief Financial Officer | Dec 17, 2020 | Sale | $1.36 | 68,550 | 93,228 | 121,272 | Dec 18, 2020, 04:15 PM |
BRENNER LOUIS MD | President and CEO | Dec 17, 2020 | Sale | $1.36 | 103,116 | 140,238 | 144,816 | Dec 18, 2020, 04:15 PM |
WHOLIHAN EDWARD | Chief Financial Officer | May 09, 2018 | Option Exercise | $1.59 | 25,000 | 39,750 | 25,000 | May 10, 2018, 11:27 AM |
HBM BioCapital II LP | 10% Owner | Nov 06, 2017 | Buy | $14.00 | 71,428 | 999,992 | 1,638,330 | Nov 08, 2017, 05:51 PM |
Bessemer Venture Partners VII L.P. | 10% Owner | Nov 06, 2017 | Buy | $14.00 | 36,000 | 504,000 | 2,263,365 | Nov 06, 2017, 07:45 PM |
Topper James N | Director | Nov 06, 2017 | Buy | $14.00 | 500,000 | 7,000,000 | 3,330,373 | Nov 06, 2017, 07:06 PM |
TEPPER ROBERT I | Director | Nov 06, 2017 | Buy | $14.00 | 215,000 | 3,010,000 | 2,790,964 | Nov 06, 2017, 07:04 PM |
FHM VI, L.L.C. | 10% Owner | Nov 06, 2017 | Buy | $14.00 | 500,000 | 7,000,000 | 3,330,373 | Nov 06, 2017, 06:46 PM |
Third Rock Ventures II, L.P. | 10% Owner | Nov 06, 2017 | Buy | $14.00 | 215,000 | 3,010,000 | 2,790,964 | Nov 06, 2017, 04:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
BRENNER LOUIS MD | President and CEO | 11/15/2021 | 32,666 |
WHOLIHAN EDWARD | Chief Financial Officer | 12/17/2020 | 93,228 |
BRENNER LOUIS MD | President and CEO | 12/17/2020 | 140,238 |
WHOLIHAN EDWARD | Chief Financial Officer | 05/09/2018 | 39,750 |
HBM BioCapital II LP | 10% Owner | 11/06/2017 | 999,992 |
Bessemer Venture Partners VII L.P. | 10% Owner | 11/06/2017 | 504,000 |
Topper James N | Director | 11/06/2017 | 7,000,000 |
TEPPER ROBERT I | Director | 11/06/2017 | 3,010,000 |
FHM VI, L.L.C. | 10% Owner | 11/06/2017 | 7,000,000 |
Third Rock Ventures II, L.P. | 10% Owner | 11/06/2017 | 3,010,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ALLENA PHARMACEUTICALS INC
LOADING...